FAU own research funding: EFI / IZKF / EAM ...
Start date : 01.01.2025
End date : 31.12.2025
Lipid nanocapsules, functionalized with RGD sequence to target ?V?3 integrin receptor on podocytes and loaded with therapeutic substances will be investigated as a podocyte specific therapeutic strategy. Uptake and therapeutic potential of loaded nanoparticles to rescue proteinuric phenotypes will be investigated in different zebrafish glomerular disease models. These experiments enable in vivo analysis of nanocarriers as potential cell type specific drug delivery systems.